Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

EXIT-CVD

Project description

Transforming cardiovascular disease with multiple ‘exit points’

Cardiovascular disease (CVD) remains Europe’s leading cause of death. The ambitious EU-funded EXIT-CVD project will tackle CVD as a preventable continuum, identifying strategic points where disease progression can be disrupted. Clinical studies will focus on early detection, intermediate stratification, and late-stage recovery via approaches including wearable monitors and heart muscle engineering. Innovations will be positioned for uptake with quantitative analyses of acceptability, feasibility, fidelity and cost, as well as a FAIR-compliant platform aligned with the European Health Data Space. Finally, the team will address persistent socioeconomic, gender and digital access disparities in care. Implementation science frameworks, equity-by-design principles, and co-creation with patients could transform CVD from a terminal continuum into a preventable and reversible condition.

Objective

"EXIT-CVD aims to fundamentally transform cardiovascular disease (CVD) management by enabling early, personalized, and equitable interventions across the CVD continuum. Recognizing CVD as a dynamic progression, from risk factors to heart failure and premature death, EXIT-CVD identifies and operationalizes strategic ""exit points"" where disease trajectories can be disrupted. Through a multidisciplinary, public-private partnership involving academia, Medtech, pharma, SMEs, and patient organizations, the project will integrate state-of-the-art diagnostics (e.g. photon-counting CT, AI-enhanced wearables), digital monitoring, regenerative therapies, and advanced imaging-guided interventions. Innovations are embedded in a digitally enabled, FAIR-compliant data platform aligned with the European Health Data Space (EHDS), ensuring real-world scalability and regulatory readiness. EXIT-CVD rigorously applies implementation science through the frameworks RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) which evaluates interventions along five core dimensions relevant to health systems uptake, and PROCTOR (Implementation Outcomes Framework) which focuses on concrete metrics such as acceptability, feasibility, fidelity, and cost. Additionally, EXIT-CVD adopts an equity-by-design approach to overcome persistent health disparities. Clinical studies target early detection (e.g. wearable blood pressure and AI-Electrocardiogram monitoring), intermediate stratification (e.g. imaging-guided Percutaneous Coronary Intervention (PCI) with Photon-Counting Computed Tomography (PCCT)), and late-stage recovery (e.g. engineered heart muscle transplantation and minimally invasive cardiac surgery supported by mechanical circulatory devices). By co-creating with patients and systematically addressing socioeconomic, gender, and digital access gaps, EXIT-CVD envisions a future where heart disease is not a terminal continuum but a preventable and reversible condition. This project will deliver validated, sustainable, and equitable innovations, positioning Europe at the forefront of cardiovascular health transformation."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-JU-RIA - HORIZON JU Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-JU-IHI-2025-09-single-stage

See all projects funded under this call

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN
Net EU contribution
€ 2 601 956,92
Address
HANZEPLEIN 1
9713 GZ Groningen
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 601 956,93

Participants (42)